Monterey Bio Acquisition Valuation
| MTRYWDelisted Stock | USD 0.03 0.00 0.00% |
Monterey Bio seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Monterey Bio Acquisition from analyzing the firm fundamentals such as Total Debt of 175.41 K, net income of (1.27 M), and Number Of Shares Shorted of 29.57 K as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Monterey Bio's price fluctuation is not too volatile at this time. Calculation of the real value of Monterey Bio Acquisition is based on 3 months time horizon. Increasing Monterey Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Monterey stock is determined by what a typical buyer is willing to pay for full or partial control of Monterey Bio Acquisition. Since Monterey Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Monterey Stock. However, Monterey Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.026 | Real 0.0236 | Hype 0.03 | Naive 0.0269 |
The intrinsic value of Monterey Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Monterey Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Monterey Bio Acquisition helps investors to forecast how Monterey stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Monterey Bio more accurately as focusing exclusively on Monterey Bio's fundamentals will not take into account other important factors: Monterey Bio Total Value Analysis
Monterey Bio Acquisition is now anticipated to have takeover price of 0 with market capitalization of 0, debt of 175.41 K, and cash on hands of 6.76 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Monterey Bio fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 175.41 K | 6.76 K |
Monterey Bio Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Monterey indicates not a very effective usage of assets in February.Monterey Bio Profitability Analysis
Net Loss for the year was (1.27 M) with profit before overhead, payroll, taxes, and interest of 0.About Monterey Bio Valuation
Our relative valuation model uses a comparative analysis of Monterey Bio. We calculate exposure to Monterey Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Monterey Bio's related companies.Monterey Bio Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York. Monterey Bio operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.
Monterey Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Monterey Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.9 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Monterey Stock
If you are still planning to invest in Monterey Bio Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Monterey Bio's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |